Hormone replacement therapy may reduce the risk of COVID-19 death in postmenopausal women
Hormone replacement therapy may reduce the risk of COVID-19 death in postmenopausal women

Hormone replacement therapy may reduce the risk of COVID-19 death in postmenopausal women

Postmenopausal women who have higher estrogen levels as a result of taking hormone replacement therapy (HRT) may have a lower risk of death from COVID-19 than women with natural levels of the hormone, a new Swedish study shows.

The research, published February 14 in BMJ openalso found that women who took estrogen-blocking therapy because of a past breast cancer diagnosis had more than twice the risk of dying; on the other hand, after researchers adjusted for several factors that could affect COVID-19 risk, the correlation was no longer statistically significant.

About 4 percent of American women take hormone therapy

Estrogen is a group of hormones produced by a woman’s ovaries. As women get older and approach menopause, their ovaries produce less estrogen. HRT can be prescribed to relieve some symptoms of menopause (primarily hot flashes) by increasing estrogen levels.

There are some women who should not use HRT, including those who have problems with vaginal bleeding, who have had certain cancers, or who have had a stroke, heart attack, blood clots or liver diseaseaccording to MedlinePlus.

Leave a Reply

Your email address will not be published.